PMID: 10107845Oct 6, 1990Paper

Using hospital-specific costs to improve the fairness of prospective reimbursement

Journal of Health Economics
G C Pope


Payment rates in Medicare's Prospective Payment System (PPS) are based on averages of historical hospital costs. Compared to reimbursing each hospital's own costs, pricing at the average of costs implies a massive redistribution of payments among hospitals. Because not all sources of hospital costs are accounted for in the PPS, some of this redistribution is 'unfair'. Information in hospital-specific costs on unmeasured patient severity and input prices can be exploited to reduce payment inequities. However, fully hospital-specific rates are not optimal because costs also reflect treatment intensity and efficiency differences among hospitals.


Oct 1, 1987·The New England Journal of Medicine·J FederS Zuckerman
Jul 10, 1983·Journal of Health Economics·P L Joskow
Feb 9, 1987·Journal of Health Economics·R C Van Vliet, B M Van Praag
May 10, 1986·Journal of Health Economics·R P Ellis, T G McGuire
May 9, 1989·Journal of Health Economics·A M Hendricks
May 9, 1989·Journal of Health Economics·G C Pope
Aug 7, 1988·Journal of Health Economics·R P Ellis, T G McGuire

❮ Previous
Next ❯


Jan 1, 1996·Journal of Mental Health Administration·E M FosterR C Saunders
May 26, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·David CrainichAna Mauleon
Jun 24, 2008·International Journal of Health Care Finance and Economics·David CrainichAna Mauleon
Oct 6, 1990·Journal of Health Economics·E B Keeler
Sep 5, 1994·Journal of Health Economics·J P Newhouse
Mar 4, 1994·The Journal of Economic Perspectives : a Journal of the American Economic Association·R P Ellis, T G McGuire
May 23, 2015·Health Policy·Jason M Sutherland
Oct 26, 2018·Cost Effectiveness and Resource Allocation : C/E·Abdelbaste HrifachCyrille Colin
Feb 11, 2005·Applied Health Economics and Health Policy·Karen Eggleston, Chee-Ruey Hsieh

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.